A detailed history of Elgethun Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Elgethun Capital Management holds 24,633 shares of LLY stock, worth $21.8 Million. This represents 6.17% of its overall portfolio holdings.

Number of Shares
24,633
Previous 23,541 4.64%
Holding current value
$21.8 Million
Previous $18.3 Million 21.78%
% of portfolio
6.17%
Previous 5.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $791,558 - $992,671
1,092 Added 4.64%
24,633 $22.3 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $6.88 Million - $9.21 Million
11,625 Added 97.56%
23,541 $18.3 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1.2 Million - $1.65 Million
2,750 Added 30.0%
11,916 $6.4 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $94,625 - $108,600
-1,250 Reduced 12.0%
9,166 $783,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $802,761 - $890,984
10,416
10,416 $891,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Elgethun Capital Management Portfolio

Follow Elgethun Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.